Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,666,667
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
27,463,580
-
Shares change
-
-319,179
-
Total reported value, excl. options
-
$87,327,663
-
Value change
-
-$3,132,332
-
Number of buys
-
32
-
Number of sells
-
-48
-
Price
-
$3.18
Significant Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q4 2018
97 filings reported holding HBIO - HARVARD BIOSCIENCE INC - Common Stock as of Q4 2018.
HARVARD BIOSCIENCE INC - Common Stock (HBIO) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27,463,580 shares
of 44,666,667 outstanding shares and own 61% of the company stock.
Largest 10 shareholders include First Light Asset Management, LLC (7,009,586 shares), BlackRock Inc. (3,067,176 shares), DIMENSIONAL FUND ADVISORS LP (1,987,089 shares), Vanguard Group Inc (1,841,800 shares), ROYCE & ASSOCIATES LP (1,730,200 shares), HEARTLAND ADVISORS INC (1,107,777 shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (1,091,683 shares), ACADIAN ASSET MANAGEMENT LLC (808,949 shares), RENAISSANCE TECHNOLOGIES LLC (699,910 shares), and BRIDGEWAY CAPITAL MANAGEMENT INC (639,417 shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.